Key TakeawaysVestal Point Capital, a firm managing $5. 47 billion, held none of its Abbott Laboratories, Revolution Medicines or BioCryst Pharmaceuticals shares by Sept.
Key TakeawaysVestal Point Capital, a firm managing $5. 47 billion, held none of its Abbott Laboratories, Revolution Medicines or BioCryst Pharmaceuticals shares by Sept.